Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,659
archived clinical trials in
Metabolic

OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
Status: Enrolling
Updated:  9/26/2015
Institute of Child Health
mi
from
London,
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
Status: Enrolling
Updated: 9/26/2015
Institute of Child Health
mi
from
London,
Click here to add this to my saved trials
Registry of Fabry Disease - A Multicenter Observational Study
Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Registry of Fabry Disease - A Multicenter Observational Study
Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Registry of Fabry Disease - A Multicenter Observational Study
Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study
Status: Enrolling
Updated:  9/26/2015
Transkaryotic Therapies, Inc.
mi
from
Cambridge, MA
Registry of Fabry Disease - A Multicenter Observational Study
Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study
Status: Enrolling
Updated: 9/26/2015
Transkaryotic Therapies, Inc.
mi
from
Cambridge, MA
Click here to add this to my saved trials
Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
A Study to Collect Normative Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
A Study to Collect Normative Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease
Status: Enrolling
Updated:  9/26/2015
National Institute of Neurological Disorders and Stroke (NINDS)
mi
from
Bethesda, MD
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease
Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease
Status: Enrolling
Updated: 9/26/2015
National Institute of Neurological Disorders and Stroke (NINDS)
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Miami, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Louisville, KY
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Oklahoma City, OK
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Muscle Shoals, AL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigational Site
mi
from
Glendale, AZ
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Encinitas, CA
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Colorado Springs, CO
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Brandon, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Brandon, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Ocala, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Ocala, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Orange City, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Orange City, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Orlando, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Port Orange, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
St. Petersburg, FL
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Oxon Hill, MD
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Butte, MT
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Butte, MT
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Cary, NC
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Cary, NC
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Salisbury, NC
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Lyndhurst, OH
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Marion, OH
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Marion, OH
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Tulsa, OK
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Eugene, OR
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Eugene, OR
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Lansdale, PA
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Lansdale, PA
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Bristol, TN
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Bristol, TN
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Boerne, TX
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Boerne, TX
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Corpus Christi, TX
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Houston, TX
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  10/5/2015
Novartis Investigative Site
mi
from
Chicoutimi,
A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 10/5/2015
Novartis Investigative Site
mi
from
Chicoutimi,
Click here to add this to my saved trials
A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
A Phase I/II, Randomized, Safety and Ascending Dose Ranging Study of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
Status: Enrolling
Updated:  10/6/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
A Phase I/II, Randomized, Safety and Ascending Dose Ranging Study of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
Status: Enrolling
Updated: 10/6/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
A Phase I/II, Randomized, Safety and Ascending Dose Ranging Study of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
Status: Enrolling
Updated:  10/6/2015
Birmingham Children's Hospital
mi
from
Birmingham,
A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
A Phase I/II, Randomized, Safety and Ascending Dose Ranging Study of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase in Pediatric Patients With Hunter Syndrome and Cognitive Impairment
Status: Enrolling
Updated: 10/6/2015
Birmingham Children's Hospital
mi
from
Birmingham,
Click here to add this to my saved trials
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated:  10/6/2015
Emory University
mi
from
Decatur, GA
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated: 10/6/2015
Emory University
mi
from
Decatur, GA
Click here to add this to my saved trials
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated:  10/6/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated: 10/6/2015
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated:  10/6/2015
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated: 10/6/2015
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated:  10/6/2015
University of North Carolina, Division of Genetics and Metabolism
mi
from
Chapel Hill, NC
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated: 10/6/2015
University of North Carolina, Division of Genetics and Metabolism
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated:  10/6/2015
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated: 10/6/2015
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated:  10/6/2015
Central Manchester University Hospitals NHS Foundation Trust, St. Mary's Hospital
mi
from
Manchester,
Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients With Hunter Syndrome
Status: Enrolling
Updated: 10/6/2015
Central Manchester University Hospitals NHS Foundation Trust, St. Mary's Hospital
mi
from
Manchester,
Click here to add this to my saved trials
Predictors of Response to Fenofibrate
Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy
Status: Enrolling
Updated:  10/11/2015
UAB Kirklin Clinic
mi
from
Birmingham, AL
Predictors of Response to Fenofibrate
Pretreatment Genotyping at APOA5 and GCKR Loci and Response to Fenofibrate Therapy
Status: Enrolling
Updated: 10/11/2015
UAB Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
Yale University School of Medicine
mi
from
New Haven, CT
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
Duke Univ Med Ctr
mi
from
Durham, NC
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
O & O Alpan
mi
from
Springfield, VA
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
O & O Alpan
mi
from
Springfield, VA
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
UCSF MS Center
mi
from
San Francisco, CA
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
UCSF MS Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
Emory University Medical Genetics
mi
from
Decatur, GA
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
Emory University Medical Genetics
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
University of Kansas Medical Center, Division of Hematology/Oncology, Dept. of Medicine
mi
from
Westwood, KA
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
University of Kansas Medical Center, Division of Hematology/Oncology, Dept. of Medicine
mi
from
Westwood, KA
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
New York University School of Medicine, Neurology Department
mi
from
New York, NY
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
New York University School of Medicine, Neurology Department
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated:  10/16/2015
Mount Sinai School of Medicine
mi
from
New York, NY
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 (ENGAGE)
Status: Enrolling
Updated: 10/16/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials